FUJIFILM Sonosite manufactures point-of-care ultrasound systems. This catalog wave covers the Sonosite PX system and its documented transducer, stand, connectivity, and security choices. Local service performance and commercial terms remain buyer checks.
HQBothell, WAFOUNDED1998REVENUENot separately disclosedCOUNTRIESNot reconciled for this profile
FUJIFILM Sonosite is headquartered in Bothell, WA and was founded in 1998, which means the company has been building medical devices for 28 years. The company operates in Not reconciled for this profile and remains privately held. Annual revenue is approximately Not separately disclosed. FUJIFILM Sonosite manufactures point-of-care ultrasound systems. This catalog wave covers the Sonosite PX system and its documented transducer, stand, connectivity, and security choices. Local service performance and commercial terms remain buyer checks.
The company's product portfolio centers on Portable point-of-care ultrasound, Touch and physical controls, DICOM workflow and security controls, with platforms targeting 1 device category: pocus ultrasound. Portfolio breadth matters for buyers because manufacturers with multiple platforms can bundle training, service contracts, and consumable agreements across devices. Single-category manufacturers typically have less negotiating flexibility, though they can offer deeper expertise in their specific domain. When evaluating FUJIFILM Sonosite, the right question is not whether the portfolio is wide or narrow, but whether the specific platform you need is strategically important to the company or a legacy product being phased out.
Manufacturer financial stability is a real consideration for capital equipment buyers. FUJIFILM Sonosite's private structure means less financial transparency, though 28 years of continuous operation is itself a meaningful signal of stability. For physicians considering a FUJIFILM Sonosite platform, the questions worth asking are warranty term length, parts availability commitments, software update policy, and service response times in your specific region. Manufacturers in financial distress sometimes cut these obligations first, and they rarely announce it publicly. The strongest signal of real manufacturer health is whether they are investing in new product development, acquiring complementary technology, or coasting on existing revenue.
Technology Platform
FUJIFILM Sonosite's core technology stack includes Portable point-of-care ultrasound, Touch and physical controls, DICOM workflow and security controls. Each platform represents distinct R&D investment and targets specific clinical indications. Physicians evaluating FUJIFILM Sonosite devices should understand which technology drives which platform because the mechanism of action varies across the company's product lineup.
The technology portfolio is deeper than a single-platform manufacturer, which matters for practices that want to consolidate device purchases with one vendor for training, service, and consumable efficiency. Platform breadth also signals R&D commitment, though it can stretch engineering and support resources thin when the company expands into too many categories at once.
Portable point-of-care ultrasound
Touch and physical controls
DICOM workflow and security controls
Product Lineup
FUJIFILM Sonosite currently produces the devices listed below across 1 category. Each device links to a full independent review with pricing, clinical evidence, pros and cons, and comparisons against category alternatives.
FUJIFILM Sonosite competes across 1 device category, which positions the company differently in each market segment. In some categories, FUJIFILM Sonosite leads on installed base and brand recognition. In others, the company is the value alternative or the technology challenger. Buyers should evaluate the company category by category rather than treating it as uniformly strong or weak across its entire portfolio.
The competitive set varies by category. In pocus ultrasound, FUJIFILM Sonosite faces a different competitive landscape than in any other segment. Some categories are dominated by 2-3 incumbents. Others are fragmenting as new entrants push on price or differentiate on clinical evidence. For physicians evaluating FUJIFILM Sonosite platforms, the right question is not whether the company is good or bad in general, but how well its specific platform stacks up against the named competitors in your category of interest.
Strengths and Weaknesses
FUJIFILM Sonosite's strengths typically include manufacturer scale (Not separately disclosed in annual revenue), international presence (Not reconciled for this profile), and a long privately held structure. Companies with this profile usually have stronger sales infrastructure, better training programs, and more predictable parts and service support than smaller competitors. The technology portfolio (Portable point-of-care ultrasound, Touch and physical controls) represents real R&D investment that smaller players can't match.
Weaknesses to weigh: any large manufacturer faces pricing pressure from value-tier competitors, distribution challenges in regions where dealer networks are thin, and the constant risk that a clinical safety signal in one product affects perception of the entire portfolio. Physicians evaluating FUJIFILM Sonosite should look at the specific platform they're considering rather than the parent brand. A strong manufacturer can have weak platforms in specific categories, and a struggling manufacturer can have category-leading products. Brand-level reputation is a starting point, not a substitute for platform-level diligence.
Who Should Consider FUJIFILM Sonosite
FUJIFILM Sonosite fits best for practices that value long manufacturer history and established product lines, want access to platforms across 1 category, and benefit from international support infrastructure. Practices that prioritize bundled training, multi-device service contracts, or trade-in programs across a manufacturer's portfolio also benefit from larger players like FUJIFILM Sonosite.
The fit is weaker for practices that prioritize the absolute lowest price, want to work with smaller manufacturers that offer more personalized service, or need niche features that only specialist competitors provide. The right manufacturer depends on what your practice values more than the manufacturer itself. Match the company to your priorities, not the other way around.
Risk Factors for Buyers
Every medical device purchase carries manufacturer risk. FUJIFILM Sonosite's risk profile reflects its size (Not separately disclosed), history (28 years of operation), and structure (private ownership). Private-company opacity cuts both ways. You lose the quarterly financial visibility that public filings provide, but you also avoid some of the short-term pressures that push public manufacturers to cut costs or rush products to market. The best signal of health in a private manufacturer is continuous R&D investment, expanding distribution, and executive stability. Layoffs, leadership turnover, and product discontinuations are warning signs that rarely show up in press releases.
Specific risks to monitor before signing a purchase contract with FUJIFILM Sonosite: warranty coverage (duration, what is covered, and exclusions), parts and service response times in your region (not the national average), software update policy (are updates included in the maintenance contract or charged separately?), consumable pricing stability (have consumable prices increased by more than 5% annually over the past three years?), and ownership change risk (is the company rumored to be for sale, spinning off a division, or preparing for an IPO or acquisition?). Each of these questions has a real answer that a well-informed buyer can verify through conversations with existing FUJIFILM Sonosite customers in your region.
What to Negotiate with FUJIFILM Sonosite
Capital equipment sales reps have significant pricing flexibility that practice buyers rarely fully capture. The published list price on a FUJIFILM Sonosite platform is almost never the real transaction price. Most deals close at 10-20% below list for single-device purchases and 20-30% below list for multi-device bundles. End-of-quarter and end-of-year timing gives you a real pricing advantage because reps have quota pressure to close before their fiscal period closes. Trade-in programs for older devices can reduce net cost by another 10-20%, though the trade-in valuation is often where manufacturers claw back the discount.
Beyond price, the items worth negotiating with FUJIFILM Sonosite include: extended warranty coverage (ask for 24-36 months instead of the standard 12), applicator or accessory inclusions (always ask for additional applicators, treatment tips, or probes thrown in at no cost), consumable starter packages (enough consumables to cover 60-90 days of typical practice use), training and certification (ensure multiple providers in your practice can be trained without additional fees), marketing support (co-marketing funds, patient education materials, or launch campaign support), and trade-in credit for any existing devices you are replacing. An itemized quote can expose missing scope and contract risk. Compare like-for-like configurations and put every material promise in writing.
Frequently Asked Questions
Where is FUJIFILM Sonosite headquartered?
FUJIFILM Sonosite is headquartered in Bothell, WA. The company was founded in 1998 and currently operates in Not reconciled for this profile. Annual revenue is approximately Not separately disclosed, with private financial structure.
What devices does FUJIFILM Sonosite make?
FUJIFILM Sonosite produces devices across 1 category: pocus ultrasound. Key technologies include Portable point-of-care ultrasound, Touch and physical controls, DICOM workflow and security controls. The current US-market device lineup includes Sonosite PX.
Is FUJIFILM Sonosite financially stable?
FUJIFILM Sonosite reports approximately Not separately disclosed in annual revenue. As a private company, financial details are limited, though the company has operated continuously since 1998. For capital equipment buyers, manufacturer financial stability matters because it affects warranty support, parts availability, and long-term software updates. Always verify the most recent financial position before signing a multi-year service contract.
How does FUJIFILM Sonosite compare to competitors?
FUJIFILM Sonosite competes across 1 device category, with different competitive positions in each. In some categories the company leads on installed base; in others it's a value alternative or technology challenger. The competitive set should be evaluated category by category. Physicians considering a specific FUJIFILM Sonosite platform should compare it directly against the other devices in that category, not against the manufacturer as a whole.
Where can I buy FUJIFILM Sonosite devices?
FUJIFILM Sonosite sells direct in some markets and through authorized dealers in others. Dealer presence and direct sales support vary by US region. For practices in major metro areas, multiple dealer relationships are typical. For practices in smaller markets, dealer access can be a limiting factor on training and service support. Verify dealer presence in your specific region before signing a purchase contract.
Does FUJIFILM Sonosite offer financing or leasing?
Most major device manufacturers including FUJIFILM Sonosite offer financing partnerships through third-party lenders, leasing arrangements with end-of-term buyout options, and trade-in programs for older devices. Terms vary by credit profile and total purchase size. Financing rates for capital medical equipment typically run 6-9% APR over five-year terms. Practices should always compare manufacturer financing against independent equipment lenders to ensure competitive rates.
What is FUJIFILM Sonosite known for in 2026?
As of April 2026, FUJIFILM Sonosite is known primarily for Portable point-of-care ultrasound, Touch and physical controls technologies and platforms across 1 device category. The company's market position varies by category. In some segments FUJIFILM Sonosite leads on installed base or clinical evidence depth. In others the company competes as a value alternative or technology challenger. The 28-year operating history (since 1998) gives the company an established reputation in the medical device buyer community, though buyer perception varies meaningfully by specialty and region.
Is FUJIFILM Sonosite a good company to buy from in 2026?
Whether FUJIFILM Sonosite is a good company to buy from depends on your specific platform need, regional dealer support, and total cost of ownership analysis. Strengths typically include Portable point-of-care ultrasound, the 28-year operating track record, and platform integration across the company's portfolio. Considerations: verify recent financial trajectory (private company financial transparency limited), confirm regional dealer presence and service capabilities, and check FDA MAUDE reports for recent adverse event signals. Compare against direct competitors in the specific category before committing.
What is FUJIFILM Sonosite's market position vs competitors in 2026?
FUJIFILM Sonosite's market position in 2026 varies by device category. The company competes across 1 device category (pocus ultrasound), with different competitive positions in each. In some categories FUJIFILM Sonosite leads on installed base or technology innovation. In others the company is a value alternative competing on price or specific features. To evaluate market position for the specific platform you are considering, request peer references in your specialty and region, check installed base data from industry publications, and compare clinical evidence depth across the competitive set.
What's the latest news from FUJIFILM Sonosite in 2026?
Recent FUJIFILM Sonosite updates relevant to capital equipment buyers in 2026 include periodic business updates, FDA labeling changes, software releases for installed devices, new applicator launches, and clinical evidence publications. FUJIFILM Sonosite company press releases and trade press coverage are the most reliable sources for the latest operational and financial updates. Buyers evaluating multi-year service contracts should always check the most recent updates before committing because manufacturer trajectory affects long-term support quality.